We are analyzing https://link.springer.com/article/10.1007/s00262-013-1476-9.

Title:
Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression | Cancer Immunology, Immunotherapy
Description:
The role and characteristics of tumor-associated neutrophils (TAN) in cancer are poorly defined. We have recently shown that TAN can have anti-tumorigenic (N1) or pro-tumorigenic (N2) functions. An interesting unanswered question is how the phenotype of TAN is influenced by the ongoing evolvement of tumor microenvironment. We therefore studied the phenotype and effects of TAN at different time points during tumor progression. We used two models of murine tumor cancer cell lines—Lewis lung carcinoma (LLC) and AB12 (mesothelioma). Neutrophils were studied at early and late stages and compared to each other and to neutrophils from bone marrow/periphery of naïve mice. Although there was no difference in the number of neutrophils entering the tumor, we found that at early stages of tumor development, neutrophils were almost exclusively at the periphery of the tumor. Only at later stages, neutrophils were also found scattered among the tumor cells. We further found that TAN from early tumors are more cytotoxic toward tumor cells and produce higher levels of TNF-α, NO and H2O2. In established tumors, these functions are down-regulated and TAN acquire a more pro-tumorigenic phenotype. In line with this phenotype, only depletion of neutrophils at later stages of tumor development inhibited tumor growth, possibly due to their central location in the tumor. Our work adds another important layer to the understanding of neutrophils in cancer by further characterizing the changes in TAN during time. Additional research on the functional role of TAN and differences between subsets of TAN is currently underway.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don’t know how the website earns money.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

article, google, scholar, pubmed, cas, tumor, cancer, neutrophils, tumorassociated, tan, immunol, progression, macrophages, research, fridlender, cells, role, cell, phenotype, factor, rev, mantovani, lung, growth, sica, res, immunity, privacy, cookies, content, immunology, development, access, doican, natl, usa, publish, search, protumorigenic, mishalian, bayuh, levy, zvi, gregorio, stages, mice, tumors, human, albelda, nat,

Topics {✒️}

granulocyte colony-stimulating factor month download article/chapter zvi gregorio fridlender advanced-stage gastric cancer human neutrophil-mediated cytotoxicity g-csf-nonproducing tumor cells human neutrophil-mediated lysis lps-induced neutrophil recruitment ly6g-specific monoclonal antibody article cancer immunology cell-produced interferon gamma tumor necrosis factor lung cancer research neutrophil-dependent angiogenesis enhanced irf-3/stat1 activation develop pro-tumorigenic properties neutrophil-delivered oxidative attack tumor promoting factor tumor microenvironment full article pdf hadassah medical center biswas sk privacy choices/manage cookies joint research fund fridlender zg produce higher levels related subjects activated human neutrophils liran levy author information authors cancer-related inflammation tumour tumor cell lysis g-csf-producing rose ce jr increased intracellular il-10 promote tumor growth antibody-dependent killing cancer immunology ovarian cancer cells israel cancer association european economic area interesting unanswered question lewis ce von kap-herr tumor-driven evolution initial angiogenic switch article mishalian defective nf-kappab check access

Questions {❓}

Balkwill F (2002) Tumor necrosis factor or tumor promoting factor?
Fridlender ZG, Albelda SM (2012) Tumor-associated neutrophils: friend or foe?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression
         description: The role and characteristics of tumor-associated neutrophils (TAN) in cancer are poorly defined. We have recently shown that TAN can have anti-tumorigenic (N1) or pro-tumorigenic (N2) functions. An interesting unanswered question is how the phenotype of TAN is influenced by the ongoing evolvement of tumor microenvironment. We therefore studied the phenotype and effects of TAN at different time points during tumor progression. We used two models of murine tumor cancer cell lines—Lewis lung carcinoma (LLC) and AB12 (mesothelioma). Neutrophils were studied at early and late stages and compared to each other and to neutrophils from bone marrow/periphery of naïve mice. Although there was no difference in the number of neutrophils entering the tumor, we found that at early stages of tumor development, neutrophils were almost exclusively at the periphery of the tumor. Only at later stages, neutrophils were also found scattered among the tumor cells. We further found that TAN from early tumors are more cytotoxic toward tumor cells and produce higher levels of TNF-α, NO and H2O2. In established tumors, these functions are down-regulated and TAN acquire a more pro-tumorigenic phenotype. In line with this phenotype, only depletion of neutrophils at later stages of tumor development inhibited tumor growth, possibly due to their central location in the tumor. Our work adds another important layer to the understanding of neutrophils in cancer by further characterizing the changes in TAN during time. Additional research on the functional role of TAN and differences between subsets of TAN is currently underway.
         datePublished:2013-10-04T00:00:00Z
         dateModified:2013-10-04T00:00:00Z
         pageStart:1745
         pageEnd:1756
         sameAs:https://doi.org/10.1007/s00262-013-1476-9
         keywords:
            Tumor immunology
            Tumor-associated neutrophils
            Lung cancer
            Mesothelioma
            Tumor microenvironment
            Oncology
            Immunology
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-013-1476-9/MediaObjects/262_2013_1476_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-013-1476-9/MediaObjects/262_2013_1476_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-013-1476-9/MediaObjects/262_2013_1476_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-013-1476-9/MediaObjects/262_2013_1476_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-013-1476-9/MediaObjects/262_2013_1476_Fig5_HTML.gif
         isPartOf:
            name:Cancer Immunology, Immunotherapy
            issn:
               1432-0851
               0340-7004
            volumeNumber:62
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Inbal Mishalian
               affiliation:
                     name:Hadassah-Hebrew University Medical Center
                     address:
                        name:Laboratory of Lung Cancer Research, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Rachel Bayuh
               affiliation:
                     name:Hadassah-Hebrew University Medical Center
                     address:
                        name:Laboratory of Lung Cancer Research, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Liran Levy
               affiliation:
                     name:Hadassah-Hebrew University Medical Center
                     address:
                        name:Laboratory of Lung Cancer Research, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lida Zolotarov
               affiliation:
                     name:Hadassah-Hebrew University Medical Center
                     address:
                        name:Laboratory of Lung Cancer Research, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Janna Michaeli
               affiliation:
                     name:Hadassah-Hebrew University Medical Center
                     address:
                        name:Laboratory of Lung Cancer Research, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zvi Gregorio Fridlender
               affiliation:
                     name:Hadassah-Hebrew University Medical Center
                     address:
                        name:Laboratory of Lung Cancer Research, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
                        type:PostalAddress
                     type:Organization
                     name:University of Pennsylvania
                     address:
                        name:Thoracic Oncology Research Laboratory, University of Pennsylvania, Philadelphia, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression
      description: The role and characteristics of tumor-associated neutrophils (TAN) in cancer are poorly defined. We have recently shown that TAN can have anti-tumorigenic (N1) or pro-tumorigenic (N2) functions. An interesting unanswered question is how the phenotype of TAN is influenced by the ongoing evolvement of tumor microenvironment. We therefore studied the phenotype and effects of TAN at different time points during tumor progression. We used two models of murine tumor cancer cell lines—Lewis lung carcinoma (LLC) and AB12 (mesothelioma). Neutrophils were studied at early and late stages and compared to each other and to neutrophils from bone marrow/periphery of naïve mice. Although there was no difference in the number of neutrophils entering the tumor, we found that at early stages of tumor development, neutrophils were almost exclusively at the periphery of the tumor. Only at later stages, neutrophils were also found scattered among the tumor cells. We further found that TAN from early tumors are more cytotoxic toward tumor cells and produce higher levels of TNF-α, NO and H2O2. In established tumors, these functions are down-regulated and TAN acquire a more pro-tumorigenic phenotype. In line with this phenotype, only depletion of neutrophils at later stages of tumor development inhibited tumor growth, possibly due to their central location in the tumor. Our work adds another important layer to the understanding of neutrophils in cancer by further characterizing the changes in TAN during time. Additional research on the functional role of TAN and differences between subsets of TAN is currently underway.
      datePublished:2013-10-04T00:00:00Z
      dateModified:2013-10-04T00:00:00Z
      pageStart:1745
      pageEnd:1756
      sameAs:https://doi.org/10.1007/s00262-013-1476-9
      keywords:
         Tumor immunology
         Tumor-associated neutrophils
         Lung cancer
         Mesothelioma
         Tumor microenvironment
         Oncology
         Immunology
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-013-1476-9/MediaObjects/262_2013_1476_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-013-1476-9/MediaObjects/262_2013_1476_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-013-1476-9/MediaObjects/262_2013_1476_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-013-1476-9/MediaObjects/262_2013_1476_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-013-1476-9/MediaObjects/262_2013_1476_Fig5_HTML.gif
      isPartOf:
         name:Cancer Immunology, Immunotherapy
         issn:
            1432-0851
            0340-7004
         volumeNumber:62
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Inbal Mishalian
            affiliation:
                  name:Hadassah-Hebrew University Medical Center
                  address:
                     name:Laboratory of Lung Cancer Research, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Rachel Bayuh
            affiliation:
                  name:Hadassah-Hebrew University Medical Center
                  address:
                     name:Laboratory of Lung Cancer Research, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Liran Levy
            affiliation:
                  name:Hadassah-Hebrew University Medical Center
                  address:
                     name:Laboratory of Lung Cancer Research, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lida Zolotarov
            affiliation:
                  name:Hadassah-Hebrew University Medical Center
                  address:
                     name:Laboratory of Lung Cancer Research, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Janna Michaeli
            affiliation:
                  name:Hadassah-Hebrew University Medical Center
                  address:
                     name:Laboratory of Lung Cancer Research, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zvi Gregorio Fridlender
            affiliation:
                  name:Hadassah-Hebrew University Medical Center
                  address:
                     name:Laboratory of Lung Cancer Research, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
                     type:PostalAddress
                  type:Organization
                  name:University of Pennsylvania
                  address:
                     name:Thoracic Oncology Research Laboratory, University of Pennsylvania, Philadelphia, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer Immunology, Immunotherapy
      issn:
         1432-0851
         0340-7004
      volumeNumber:62
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Hadassah-Hebrew University Medical Center
      address:
         name:Laboratory of Lung Cancer Research, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
         type:PostalAddress
      name:Hadassah-Hebrew University Medical Center
      address:
         name:Laboratory of Lung Cancer Research, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
         type:PostalAddress
      name:Hadassah-Hebrew University Medical Center
      address:
         name:Laboratory of Lung Cancer Research, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
         type:PostalAddress
      name:Hadassah-Hebrew University Medical Center
      address:
         name:Laboratory of Lung Cancer Research, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
         type:PostalAddress
      name:Hadassah-Hebrew University Medical Center
      address:
         name:Laboratory of Lung Cancer Research, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
         type:PostalAddress
      name:Hadassah-Hebrew University Medical Center
      address:
         name:Laboratory of Lung Cancer Research, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
         type:PostalAddress
      name:University of Pennsylvania
      address:
         name:Thoracic Oncology Research Laboratory, University of Pennsylvania, Philadelphia, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Inbal Mishalian
      affiliation:
            name:Hadassah-Hebrew University Medical Center
            address:
               name:Laboratory of Lung Cancer Research, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
               type:PostalAddress
            type:Organization
      name:Rachel Bayuh
      affiliation:
            name:Hadassah-Hebrew University Medical Center
            address:
               name:Laboratory of Lung Cancer Research, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
               type:PostalAddress
            type:Organization
      name:Liran Levy
      affiliation:
            name:Hadassah-Hebrew University Medical Center
            address:
               name:Laboratory of Lung Cancer Research, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
               type:PostalAddress
            type:Organization
      name:Lida Zolotarov
      affiliation:
            name:Hadassah-Hebrew University Medical Center
            address:
               name:Laboratory of Lung Cancer Research, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
               type:PostalAddress
            type:Organization
      name:Janna Michaeli
      affiliation:
            name:Hadassah-Hebrew University Medical Center
            address:
               name:Laboratory of Lung Cancer Research, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
               type:PostalAddress
            type:Organization
      name:Zvi Gregorio Fridlender
      affiliation:
            name:Hadassah-Hebrew University Medical Center
            address:
               name:Laboratory of Lung Cancer Research, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
               type:PostalAddress
            type:Organization
            name:University of Pennsylvania
            address:
               name:Thoracic Oncology Research Laboratory, University of Pennsylvania, Philadelphia, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Laboratory of Lung Cancer Research, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
      name:Laboratory of Lung Cancer Research, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
      name:Laboratory of Lung Cancer Research, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
      name:Laboratory of Lung Cancer Research, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
      name:Laboratory of Lung Cancer Research, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
      name:Laboratory of Lung Cancer Research, Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
      name:Thoracic Oncology Research Laboratory, University of Pennsylvania, Philadelphia, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(212)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

3.95s.

LINK . SPRINGER . COM {}